The Safety Pharmacology Society (SPS) meeting will be held Septemeber 18 – 21 at the SQUARE Brussels Meeting Centre in Belgium. Stop by our booth No. 505 as well as poster and oral presentations.
SPS 2023 FLEXcyte Posters
#095 In Vitro Systems for the Assessment of Chronic Cardiotoxic Effects: News from the HESI Stem Cell Working Group
#132 From Neat Compounds to Complex Mixtures: A Potential Screening Strategy for Cardiotoxic Potential of Botanicals
#037 FLEXcyte 96: Removing Obstacles for hiPSC- Derived Cardiomyocytes in Preclinical Drug Development
#099 Contractility-Based Pharmacological Characterization of hiPSC-Derived Atrial and Ventricular Cardiomyocytes Assessed on the FLEXcyte 96
#111 Assay Development and Validation to Measure Contraction Force from co-culture of Human iPSC-derived Cardiomyocytes and Cardiac Fibroblasts on the FLEXcyte 96 System
SPS 2023 Oral Presentations
Tuesday, September 19, 1:45 pm – 2 pm. Session 2 In Vitro Cardiovascular
Presenter: Bettina Lickiss
Talk Title: Contractility‐Based Pharmacological Characterization of hiPSC‐Derived Atrial and Ventricular Cardiomyocytes Assessed on the FLEXcyte 96
–
Wednesday, September 20, 12:30 pm – 1:30 pm. FCDI and Nanion Technologies Partner Talk, Meeting Studio 212
Presenter: Matthias Gossmann
Talk Title: FLEXcyte 96 and iCell Cardiomyocytes²: A Comprehensive Toolbox for the Evaluation of Chronic Drug-Induced Cardiotoxicity
